You are here

Electrophysiology & Arrhythmia

 

The American College of Cardiology (ACC) and American Heart Association (AHA) released updated clinical performance and quality measure sets on June 27 for adults with atrial fibrillation or atrial flutter.

 

 

Recent Headlines

ACC, AHA release updated measure sets for atrial fibrillation

The American College of Cardiology (ACC) and American Heart Association (AHA) released updated clinical performance and quality measure sets on June 27 for adults with atrial fibrillation or atrial flutter.

Abbott presents positive findings of three trials evaluating its RhythmView technology for atrial fibrillation

Patients with atrial fibrillation had positive results after receiving treatment with focal impulse rotor modulation (FIRM)-guided rotor ablation, according to three studies presented at the recent Cardiostim-EHRA Europace conference in Nice, France.

Follow-up analysis shows the Micra TPS is associated with lower risk of major complications

After 7.7 months, patients who were implanted with the Micra Transcatheter Pacing System (TPS) had a statistically significant 52 percent lower risk for major complications compared with those who received a conventional pacing system.

Patients vs. Populations: Afib Experts Get Energized Over Quality Metrics & Training

Five electrophysiologists joined Cardiovascular Business editorial advisor Matthew R. Reynolds, MD, SM, for a discussion about how they will deliver quality care to a growing number of atrial fibrillation patients even as the U.S. healthcare system turns its focus from volume to value.

CMS seeks comments on leadless cardiac pacemakers

The Centers for Medicare & Medicaid Services (CMS) announced on May 18 that it was initiating a national coverage analysis for leadless cardiac pacemakers.

Medicare patients experience high rates of complications and reoperations following ICD implantation

An observational cohort study found that Medicare patients had a high rate of device-related complications and reoperations for other causes following implantation with implantable cardioverter-defibrillators (ICDs).

HRS.16: Two physicians receive grants for atrial fibrillation research

Two physicians received a total of $500,000 in grants from the Heart Rhythm Society (HRS) and Boehringer Ingelheim Pharmaceuticals to support quality improvement research on atrial fibrillation and stroke prevention.

HRS.16: S-ICD system is safe for patients at risk for sudden cardiac arrest

After 360 days, 98 percent of patients who were implanted with Boston Scientific’s subcutaneous implantable defibrillator (S-ICD) system were free from complications, according to a multi-national registry.

HRS.16: Hispanics, African Americans with heart failure are at lower risk of developing atrial fibrillation

A retrospective analysis found Hispanic and African American patients with heart failure had a lower risk of developing atrial fibrillation compared with white patients who had heart failure.

HRS.16: Ganglionic plexus ablation leads to worse outcomes in AFib patients

A randomized trial of patients undergoing thoracoscopic surgery for advanced atrial fibrillation found that additional ganglionic plexus ablation was associated with significantly more periprocedural major bleeding, sinus node dysfunction and pacemaker implantation. Patients in the ganglionic plexus ablation group also did not have improvements in rhythm outcomes.

Pages